# Wonbiogen registers wound dressing products with US FDA

Wonbiogen completed US FDA registration for hydrocolloid wound dressing products, enabling export expansion to North America. The company is negotiating supply contracts with US companies and plans to build a dedicated production plant.

- Type: Product launch
- Announced: 2021-06-07
- Where: United States
- Status: announced
- Products: hydrocolloid wound dressings, liquid silicone scar dressings, functional cosmetics
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Wonbiogen](https://endata.com/companies/55646.md)

## Sources

- [asiae.co.kr](https://www.asiae.co.kr/en/article/2021060710390527871), 2021-06-07: "With this US FDA registration as the starting point, our export activities to North America will expand further, laying the foundation for future growth."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.